# Biotechnology — Industry Hub

> Quantitative analysis from TrendMatrix. Data for informational use only — not investment advice.

Biotech companies develop drugs, therapies, and diagnostics through biological and genetic research, with business models dependent on FDA approvals and patent-protected exclusivity. Key risks include lengthy regulatory timelines with uncertain outcomes, patent cliff events where expiring exclusivity can eliminate revenues, and pricing pressure from government and insurers. TrendMatrix ranks 150 US-listed Biotechnology stocks by 10-dimension quantitative score, refreshed every 5 minutes during market hours with a full reanalysis nightly.

- **Parent sector:** Healthcare
- **Stocks tracked:** 151 (primer N: 150)
- **Sentiment:** 8 bullish · 12 neutral · 131 bearish · avg score 5.16
- **Last updated:** 2026-04-25T16:28:11+00:00

## Ranked Stocks

| # | Symbol | Name | Verdict | Score | Price | Upside |
|---|---|---|---|---|---|---|
| 1 | [INCY](https://trendmatrix.com/stocks/INCY) | Incyte Corporation | STRONG_BUY_WAIT | 7.0 | $98.05 | +7.2% |
| 2 | [AUPH](https://trendmatrix.com/stocks/AUPH) | Aurinia Pharmaceuticals Inc | STRONG_BUY_WAIT | 6.9 | $15.52 | +8.0% |
| 3 | [GLPG](https://trendmatrix.com/stocks/GLPG) | Galapagos NV | STRONG_BUY_WAIT | 6.5 | $27.93 | +6.3% |
| 4 | [HALO](https://trendmatrix.com/stocks/HALO) | Halozyme Therapeutics, Inc. | STRONG_BUY_WAIT | 6.5 | $63.95 | +18.0% |
| 5 | [LGND](https://trendmatrix.com/stocks/LGND) | Ligand Pharmaceuticals Incorpor | STRONG_BUY_WAIT | 6.0 | $225.53 | +12.9% |
| 6 | [CORT](https://trendmatrix.com/stocks/CORT) | Corcept Therapeutics Incorporat | STRONG_BUY_WAIT | 5.9 | $46.63 | +30.1% |
| 7 | [ADPT](https://trendmatrix.com/stocks/ADPT) | Adaptive Biotechnologies Corpor | STRONG_BUY_WAIT | 5.7 | $14.08 | +33.8% |
| 8 | [ASND](https://trendmatrix.com/stocks/ASND) | Ascendis Pharma A/S | STRONG_BUY_WAIT | 5.4 | $228.51 | +14.4% |
| 9 | [HRMY](https://trendmatrix.com/stocks/HRMY) | Harmony Biosciences Holdings, I | HOLD_IF_HOLDING | 6.9 | $31.18 | +20.0% |
| 10 | [CPRX](https://trendmatrix.com/stocks/CPRX) | Catalyst Pharmaceuticals, Inc. | HOLD_IF_HOLDING | 6.8 | $28.37 | +4.1% |
| 11 | [INVA](https://trendmatrix.com/stocks/INVA) | Innoviva, Inc. | HOLD_IF_HOLDING | 6.7 | $23.20 | +24.5% |
| 12 | [PHAR](https://trendmatrix.com/stocks/PHAR) | Pharming Group N.V. | HOLD_IF_HOLDING | 6.6 | $16.44 | +78.9% |
| 13 | [AAPG](https://trendmatrix.com/stocks/AAPG) | Ascentage Pharma Group Internat | HOLD_IF_HOLDING | 6.3 | $22.88 | +82.1% |
| 14 | [ONC](https://trendmatrix.com/stocks/ONC) | BeOne Medicines Ltd. | HOLD_IF_HOLDING | 6.3 | $295.75 | +24.0% |
| 15 | [ARGX](https://trendmatrix.com/stocks/ARGX) | argenx SE | HOLD_IF_HOLDING | 5.9 | $781.92 | +18.8% |
| 16 | [CAI](https://trendmatrix.com/stocks/CAI) | Caris Life Sciences, Inc. | HOLD_IF_HOLDING | 5.9 | $18.80 | +37.3% |
| 17 | [GERN](https://trendmatrix.com/stocks/GERN) | Geron Corporation | HOLD_IF_HOLDING | 5.6 | $1.54 | +92.2% |
| 18 | [IVA](https://trendmatrix.com/stocks/IVA) | Inventiva S.A. - American Depos | HOLD_IF_HOLDING | 5.6 | $5.13 | +156.5% |
| 19 | [SVRA](https://trendmatrix.com/stocks/SVRA) | Savara, Inc. | HOLD_IF_HOLDING | 5.1 | $5.08 | +85.1% |
| 20 | [ORIC](https://trendmatrix.com/stocks/ORIC) | Oric Pharmaceuticals, Inc. | HOLD_IF_HOLDING | 4.8 | $9.55 | +90.2% |
| 21 | [NVAX](https://trendmatrix.com/stocks/NVAX) | Novavax, Inc. | SELL_IF_HOLDING | 6.9 | $8.12 | +50.0% |
| 22 | [ACAD](https://trendmatrix.com/stocks/ACAD) | ACADIA Pharmaceuticals Inc. | SELL_IF_HOLDING | 6.2 | $22.55 | +26.6% |
| 23 | [DBVT](https://trendmatrix.com/stocks/DBVT) | DBV Technologies S.A. | SELL_IF_HOLDING | 6.2 | $21.00 | +65.8% |
| 24 | [ADMA](https://trendmatrix.com/stocks/ADMA) | ADMA Biologics Inc | SELL_IF_HOLDING | 6.1 | $10.75 | +63.4% |
| 25 | [ALNY](https://trendmatrix.com/stocks/ALNY) | Alnylam Pharmaceuticals, Inc. | SELL_IF_HOLDING | 6.1 | $309.92 | +30.5% |
| 26 | [TSHA](https://trendmatrix.com/stocks/TSHA) | Taysha Gene Therapies, Inc. | SELL_IF_HOLDING | 6.1 | $6.47 | +55.6% |
| 27 | [ARQT](https://trendmatrix.com/stocks/ARQT) | Arcutis Biotherapeutics, Inc. | SELL_IF_HOLDING | 6.0 | $23.12 | +30.9% |
| 28 | [BMRN](https://trendmatrix.com/stocks/BMRN) | BioMarin Pharmaceutical Inc. | SELL_IF_HOLDING | 6.0 | $54.50 | +48.9% |
| 29 | [EXEL](https://trendmatrix.com/stocks/EXEL) | Exelixis, Inc. | SELL_IF_HOLDING | 6.0 | $44.76 | +4.0% |
| 30 | [ANAB](https://trendmatrix.com/stocks/ANAB) | AnaptysBio, Inc. | SELL_IF_HOLDING | 5.9 | $65.11 | +5.5% |
| 31 | [TVTX](https://trendmatrix.com/stocks/TVTX) | Travere Therapeutics, Inc. | SELL_IF_HOLDING | 5.9 | $41.97 | +2.3% |
| 32 | [MIRM](https://trendmatrix.com/stocks/MIRM) | Mirum Pharmaceuticals, Inc. | SELL_IF_HOLDING | 5.8 | $96.76 | +16.6% |
| 33 | [TLX](https://trendmatrix.com/stocks/TLX) | Telix Pharmaceuticals Limited | SELL_IF_HOLDING | 5.8 | $10.88 | +68.1% |
| 34 | [AKTS](https://trendmatrix.com/stocks/AKTS) | Aktis Oncology, Inc. | SELL_IF_HOLDING | 5.7 | $19.38 | +42.5% |
| 35 | [FOLD](https://trendmatrix.com/stocks/FOLD) | Amicus Therapeutics, Inc. | SELL_IF_HOLDING | 5.7 | $14.49 | -1.9% |
| 36 | [IDYA](https://trendmatrix.com/stocks/IDYA) | IDEAYA Biosciences, Inc. | SELL_IF_HOLDING | 5.7 | $28.96 | +64.3% |
| 37 | [OCS](https://trendmatrix.com/stocks/OCS) | Oculis Holding AG | SELL_IF_HOLDING | 5.7 | $27.16 | +52.2% |
| 38 | [TARS](https://trendmatrix.com/stocks/TARS) | Tarsus Pharmaceuticals, Inc. | SELL_IF_HOLDING | 5.7 | $61.36 | +33.5% |
| 39 | [IMCR](https://trendmatrix.com/stocks/IMCR) | Immunocore Holdings plc | SELL_IF_HOLDING | 5.6 | $27.90 | +99.1% |
| 40 | [LEGN](https://trendmatrix.com/stocks/LEGN) | Legend Biotech Corporation | SELL_IF_HOLDING | 5.6 | $23.30 | +121.0% |
| 41 | [REGN](https://trendmatrix.com/stocks/REGN) | Regeneron Pharmaceuticals, Inc. | SELL_IF_HOLDING | 5.6 | $704.30 | +12.2% |
| 42 | [ARDX](https://trendmatrix.com/stocks/ARDX) | Ardelyx, Inc. | SELL_IF_HOLDING | 5.5 | $6.36 | +126.1% |
| 43 | [ARWR](https://trendmatrix.com/stocks/ARWR) | Arrowhead Pharmaceuticals, Inc. | SELL_IF_HOLDING | 5.5 | $72.98 | +0.3% |
| 44 | [IBRX](https://trendmatrix.com/stocks/IBRX) | ImmunityBio, Inc. | SELL_IF_HOLDING | 5.5 | $7.13 | +80.4% |
| 45 | [TGTX](https://trendmatrix.com/stocks/TGTX) | TG Therapeutics, Inc. | SELL_IF_HOLDING | 5.5 | $34.21 | +13.3% |
| 46 | [VRDN](https://trendmatrix.com/stocks/VRDN) | Viridian Therapeutics, Inc. | SELL_IF_HOLDING | 5.5 | $13.38 | +125.8% |
| 47 | [VRTX](https://trendmatrix.com/stocks/VRTX) | Vertex Pharmaceuticals Incorpor | SELL_IF_HOLDING | 5.5 | $429.25 | +15.0% |
| 48 | [BBIO](https://trendmatrix.com/stocks/BBIO) | BridgeBio Pharma, Inc. | SELL_IF_HOLDING | 5.4 | $70.83 | +28.2% |
| 49 | [DMRA](https://trendmatrix.com/stocks/DMRA) | Damora Therapeutics, Inc. | SELL_IF_HOLDING | 5.4 | $25.76 | +52.6% |
| 50 | [JAZZ](https://trendmatrix.com/stocks/JAZZ) | Jazz Pharmaceuticals plc | SELL_IF_HOLDING | 5.4 | $202.86 | +0.1% |

_Showing top 50 of 151 tracked. Full list at `/api/industries/biotechnology/rollup`._

## Recent 8-K Events (last 30 days)

- **DAWN** [Item 5.01] (2026-04-23): Servier Pharmaceuticals' tender offer for all Day One shares at $21.50/share expired April 22, 2026. Servier acquired all outstanding shares per Merger Agreement dated March 6, 2026. Change of control completed.
- **DAWN** [Item 1.02] (2026-04-23): Material agreement terminated upon completion of Servier merger on April 22-23, 2026, per Merger Agreement. No separate reason cited beyond merger closing.
- **DAWN** [Item 5.02] (2026-04-23): Director/officer departures upon Servier merger completion effective April 22-23, 2026; expected consequence of change-of-control closing per Merger Agreement from March 6, 2026.
- **ANAB** [Item 2.01] (2026-04-20): Spinoff of First Tracks Biotherapeutics completed April 20, 2026: AnaptysBio distributed all First Tracks shares pro rata to stockholders (1:1 ratio). First Tracks began trading on Nasdaq as TRAX. Separation and distribution agreement and transition services agreement executed.
- **TYRA** [Item 5.02] (2026-04-17): Habib J. Dable appointed to the Board as Class II director, effective upon Board approval on April 16, 2026. Previously President and CEO of Acceleron Pharma; currently advisor at RA Capital Management. No arrangement with any other person.
- **GPCR** [Item 5.02] (2026-04-15): Matthew Lang appointed Chief Operating Officer and General Counsel effective April 15, 2026. Previously CLO at Metsera and Chief Business Officer/CLO at Lyell Immunopharma. No departures noted.
- **HRMY** [Item 5.02] (2026-04-14): CFO Sandip Kapadia stepped down Apr 14, 2026 to pursue other career opportunities. Glenn Reicin appointed CFO effective Apr 14, 2026 as same-day successor. Separation Agreement entered into.
- **XENE** [Item 5.02] (2026-04-13): Xenon amended 2025 Inducement Equity Plan on April 7, 2026 to increase share reserve from 900,000 to 1,175,000 shares. Compensatory plan amendment; no officer departure or appointment.
- **PVLA** [Item 5.02] (2026-04-13): John Doux, M.D. appointed to Board as Class III director effective April 13, 2026, filling a vacancy from Board size increase from 6 to 7. Board-certified dermatologist and healthcare investor. No reason for prior vacancy cited.
- **CGON** [Item 5.02] (2026-04-13): Jim DeTore appointed CFO on April 13, 2026. DeTore had served as Interim Principal Financial and Accounting Officer since November 2025; converts interim to permanent. No disagreement cited.

## Cross-Company Themes

- **GSK** — 2 companies (INVA, ANAB)
- **AMVUTTRA** — 1 companies (ALNY)
- **ARIKAYCE and BRINSUPRI** — 1 companies (INSM)
- **AUVELITY, SUNOSI, and SYMBRAVO** — 1 companies (AXSM)
- **Akeso** — 1 companies (SMMT)

## Related Industries

- [Medical Devices](https://trendmatrix.com/industries/medical-devices) — 40 stocks
- [Drug Manufacturers - Specialty & Generic](https://trendmatrix.com/industries/drug-manufacturers-specialty-and-generic) — 29 stocks
- [Medical Care Facilities](https://trendmatrix.com/industries/medical-care-facilities) — 27 stocks
- [Medical Instruments & Supplies](https://trendmatrix.com/industries/medical-instruments-and-supplies) — 25 stocks
- [Diagnostics & Research](https://trendmatrix.com/industries/diagnostics-and-research) — 25 stocks

## Canonical Links

- HTML: https://trendmatrix.com/industries/biotechnology
- JSON: https://trendmatrix.com/api/industries/biotechnology/rollup
- Markdown: https://trendmatrix.com/industries/biotechnology.md